clinical trial · NCT07103057
VIZ ACCESS HCM - Multi-Site Registry
Viz.ai, Inc.·—·recruiting·n = 500
Hypertrophic CardiomyopathyViz HCM
brief summary
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
started
Jun 13, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Aug 17, 2025
official title
ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol